EGF-induced nuclear translocation of SHCBP1 promotes bladder cancer progression through inhibiting RACGAP1-mediated RAC1 inactivation

Bladder cancer is a highly heterogeneous and aggressive malignancy with a poor prognosis. EGF/EGFR activation causes the detachment of SHC-binding protein 1 (SHCBP1) from SHC adapter protein 1 (SHC1), which subsequently translocates into the nucleus and promotes cancer development via multiple signa...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Hubin, Zhang, Chen, Wei, Zongjie, He, Weiyang, Xu, Ning, Xu, Yingjie, Li, Tinghao, Ren, Ke, Kuang, Youlin, Zhu, Xin, Yuan, Fangchao, Yu, Haitao, Gou, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8748695/
https://www.ncbi.nlm.nih.gov/pubmed/35013128
http://dx.doi.org/10.1038/s41419-021-04479-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8748695/
https://www.ncbi.nlm.nih.gov/pubmed/35013128
http://dx.doi.org/10.1038/s41419-021-04479-w

Ejemplares similares